KR101245730B1 - A method of depolymerizing Grifola frondosa Exo-polysaccharides, Grifola frondosa Exo-polysaccharides obtained therefrom, and cosmetic composotion and food product containing them - Google Patents
A method of depolymerizing Grifola frondosa Exo-polysaccharides, Grifola frondosa Exo-polysaccharides obtained therefrom, and cosmetic composotion and food product containing them Download PDFInfo
- Publication number
- KR101245730B1 KR101245730B1 KR1020100066255A KR20100066255A KR101245730B1 KR 101245730 B1 KR101245730 B1 KR 101245730B1 KR 1020100066255 A KR1020100066255 A KR 1020100066255A KR 20100066255 A KR20100066255 A KR 20100066255A KR 101245730 B1 KR101245730 B1 KR 101245730B1
- Authority
- KR
- South Korea
- Prior art keywords
- mycelium
- molecular weight
- polysaccharide
- polysaccharides
- exo
- Prior art date
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 63
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 63
- 239000002537 cosmetic Substances 0.000 title claims abstract description 25
- 240000001080 Grifola frondosa Species 0.000 title claims description 5
- 235000007710 Grifola frondosa Nutrition 0.000 title claims description 4
- 235000013305 food Nutrition 0.000 title abstract description 15
- 238000000034 method Methods 0.000 title abstract description 10
- 150000004676 glycans Chemical class 0.000 claims abstract description 61
- 239000000203 mixture Substances 0.000 claims abstract description 32
- 230000005855 radiation Effects 0.000 claims abstract description 12
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 241000233866 Fungi Species 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 230000013632 homeostatic process Effects 0.000 claims 2
- 238000005119 centrifugation Methods 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 6
- 230000035790 physiological processes and functions Effects 0.000 abstract description 6
- 230000001093 anti-cancer Effects 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 230000009759 skin aging Effects 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 239000000284 extract Substances 0.000 description 8
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 4
- 229920002498 Beta-glucan Polymers 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000001965 potato dextrose agar Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- ZTOJFFHGPLIVKC-UHFFFAOYSA-N 3-ethyl-2-[(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C1=NN=C1SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000222518 Agaricus Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 229920000310 Alpha glucan Polymers 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000012184 tortilla Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000037330 wrinkle prevention Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 저분자화된 잎새버섯 균사체 세포외 다당체, 그의 제조방법과 그를 함유한 화장료 조성물 및 식품에 관한 것으로, 방사선 조사에 의해 잎새버섯 균사체 세포외 다당체를 저분자화함으로써 생리학적 기능을 향상시킬 수 있다. 특히, 방사선 보호 효과 및 항산화 효능이 향상되므로, 화장료 조성물에 함유시켜서 탁월한 피부 노화 방지를 나타나도록 할 수 있다. 또한, 식품에 포함될 경우, 면역증강효과 및 항암 효과를 나타낼 수 있다.The present invention relates to a low molecular weight mycelium mycelium extracellular polysaccharide, a method for preparing the same, a cosmetic composition containing the same, and a food. The physiological function can be improved by reducing the molecular weight of the leaf mycelium mycelium extracellular polysaccharide by irradiation. . In particular, since the radiation protection effect and the antioxidant effect is improved, it can be included in the cosmetic composition to exhibit excellent skin aging prevention. In addition, when included in food, it may exhibit an immune enhancing effect and an anticancer effect.
Description
본 발명은 잎새버섯 세포외다당체의 저분자화 방법, 그로부터 수득된 잎새버섯 세포외다당체와 그를 포함하는 화장료 조성물 및 식품에 관한 것으로, 보다 구체적으로는 방사선 조사에 의해 잎새버섯 균사체 세포외다당체를 저분자화함으로써 생리학적 기능을 향상시키는 것을 특징으로 하는 잎새버섯 균사체 세포외다당체의 저분자화 방법, 그로부터 수득된 잎새버섯 균사체 세포외다당체와 그를 함유한 화장료 조성물 및 식품에 관한 것이다.
The present invention relates to a low molecular weight method of leaf mushroom extracellular polysaccharide, to a leaf mushroom extracellular polysaccharide obtained therefrom, to a cosmetic composition and a food comprising the same, and more specifically to lower molecular weight of leaf mushroom mycelium extracellular polysaccharide by irradiation The present invention relates to a method for reducing the molecular weight of a leaf mycelium mycelium extracellular polysaccharide, thereby improving a physiological function, a leaf mycelium mycelium extracellular polysaccharide obtained therefrom, and a cosmetic composition and food containing the same.
버섯은 분류학상 고등균류의 담자균류(일부는 자낭균)에 속한 것으로, 세계적으로 15,000여종이 알려져 있고, 이 중 약 2,000여종이 식용으로 개발 가능하다. The mushroom belongs to the taxonomic fungus of the basidiomycetes (some of which are asymptococci), 15,000 species are known worldwide, and about 2,000 of them can be developed for food.
버섯은 균사체 및 그의 영양대사로 얻어지는 대사산물이 축적된 자실체로 구성된다. 일반 식물과 비교하자면, 균사체는 뿌리, 줄기, 잎에 해당되고, 자실체는 꽃에 해당하는데, 균사체는 자실체의 약 4배 이상의 영양소, 약 50 내지 60배 정도의 약용성분을 더 함유하고 있어 버섯의 실체라고 지칭되기도 한다. 최근에는 자실체 및 균사체의 추출물이나 균사체 배양물이 체질개선이나 각종 병의 예방과 치료에 효과가 있는 것으로 밝혀져 건강식품이나 의약품으로서의 용도가 크게 증가하고 있는 실정이다.Mushrooms consist of mycelia and fruiting bodies accumulating metabolites obtained from their metabolism. Compared to normal plants, mycelia correspond to roots, stems, and leaves, and fruiting bodies correspond to flowers. Mycelia contain more than four times the nutrients of fruiting bodies and about 50 to 60 times more medicinal ingredients. Sometimes referred to as entity. Recently, extracts of fruiting bodies and mycelium and mycelium culture have been found to be effective in improving the constitution and preventing and treating various diseases, and thus the use as health foods and medicines has been greatly increased.
특히, 버섯이 생산하는 특정 구조의 다당체는 오래 전부터 종래의 화학요법제와는 달리 숙주내 면역기능을 활성화하여 면역요법제로서의 항암효과를 나타내는 것으로 보고되고 있다. 버섯의 다당체는 세포골격을 구성하는 세포벽 다당, 세포내에 영양 저장형태로 존재하는 세포내(intracellular) 다당 및 균체외로 분비하는 세포외(extracellular) 다당의 세 가지로 나눌 수 있다. 세포벽과 세포막을 구성하는 다당체는 α-glucan, β-glucan, heteroglucan 및 chitin질 등이다. In particular, unlike the conventional chemotherapeutic agents, the polysaccharide of a specific structure produced by mushrooms has been reported to activate the immune function in the host to exhibit an anticancer effect as an immunotherapy agent. Mushroom polysaccharides can be divided into three: cell wall polysaccharide constituting the cytoskeleton, intracellular polysaccharides present in the form of nutrient storage in the cell and extracellular polysaccharides secreted extracellularly. Polysaccharides that make up cell walls and membranes are α-glucan, β-glucan, heteroglucan and chitin.
세포외다당체(exo-polysaccharides, EPS)는 생물공학 소재의 하나로, 많은 양을 수입에 의존하고 있다. 세포외다당체는 그 대부분이 식품 첨가물, 건강 보조 식품 등에 응용되고 있으며, 최근에는 화장품에 활발히 응용되어, 세포 활성 및 콜라겐 생성을 촉진하여 피부노화를 방지하고, 자외선에 의한 피부 손상, 염증, 자극 등을 완화시키며, 면역증강작용이 있다고 알려져 있다. Extracellular polysaccharides (EPs) are one of the biotechnological materials and depend on imports. Most of the extracellular polysaccharides are applied to food additives, health supplements, etc. Recently, they are actively applied to cosmetics to promote cell activity and collagen production to prevent skin aging, and to damage, irritate, and irritate skin by UV rays. It is known to alleviate the immune system.
최근 다양한 기능성 화장품의 개발이 활발히 추진되고 있는데, 주름개선, 미백 및 자외선 차단물질, 유해산소 제거, 콜라겐 합성촉진, 피부주름 방지, 면역증강 및 항염증, 육모제 등의 다양한 용도에서 천연물 화장품 소재가 제품화되고 있다. Recently, the development of various functional cosmetics has been actively promoted. Natural cosmetic products are commercialized in various applications such as wrinkle improvement, whitening and UV blocking substances, removal of harmful oxygen, promotion of collagen synthesis, skin wrinkle prevention, immunity enhancement and anti-inflammatory, hair growth agent, etc. It is becoming.
이와 관련하여, 다양한 버섯 유래의 소재들이 화장료 조성물에 응용되고 있는데, 대표적인 예로서 상황버섯, 아가리쿠스, 동충하초, 영지 버섯, 표고 버섯 등을 들 수 있다. 그러나, 이들 버섯 유래의 물질들은 대부분 자실체 추출물로서 소량 응용되고 있는 실정이다. 또한, 범용적으로 사용되는 효모 유래의 베타 글루칸은 물질 자체의 난용성 문제점이 있으며, 일부 다국적 회사에서 개발된 수용성 유도체는 고가의 가격이 문제시된다. In this regard, various mushroom-derived materials are applied to the cosmetic composition, and examples thereof include situation mushrooms, agaricus, cordyceps, ganoderma lucidum mushroom, shiitake mushrooms, and the like. However, these mushroom-derived materials are mostly applied in small amounts as fruiting body extracts. In addition, beta glucan derived from yeast that is commonly used has a problem of poor solubility of the material itself, and water-soluble derivatives developed by some multinational companies have a problem of high price.
잎새버섯(Grifola frondosa)은 분류학상 민주름버섯목, 구멍장이과, 잎새버섯 속에 해당한다. 맛이 좋은 고급 식용 버섯으로 취급되고, 면역증강기능 및 항암 효과가 우수한 것으로 알려져 있어, 다양한 건강 보조 식품으로 개발되고 있었으나, 매우 고가이어서 그 이용이 제한적이다. 또한, 잎새버섯의 주요 다당체인 베타 글루칸의 화학 구조는 다른 약용 버섯에서 발견되는 베타 글루칸의 구조와는 다르게 세포 면역 반응을 자극시키는 가장 강력한 성분으로 보고되고 있다.Leafy mushrooms (Grifola frondosa) are taxonomically belonging to the genus Democratic Mushrooms, Tortillas and Leafy Mushrooms. Treated as a high-quality edible mushroom, it is known to be excellent in immune enhancement and anti-cancer effects, and was developed as a variety of health supplements, but it is very expensive and its use is limited. In addition, the chemical structure of beta glucan, the main polysaccharide of leaf mushrooms, is reported to be the most potent ingredient that stimulates cellular immune responses, unlike the structure of beta glucan found in other medicinal mushrooms.
대한민국 특허출원 10-2008-0129473호 “잎새버섯 균사체 배양물 및 면역활성 다당체의 대량 생산 방법”에는 액체배양 기술을 이용하여 잎새버섯의 균사체 배양물 및 다당체를 대량 생산하는 방법에 대하여 기재하고 있고, Republic of Korea Patent Application No. 10-2008-0129473 "Mushroom mycelium culture and mass production method of immuno-active polysaccharide" describes a method for mass production of mycelium culture and polysaccharide of leaf mushroom using liquid culture technology,
대한민국 등록특허 제10-0438009호 “잎새버섯 균사체의 추출물을 함유하는 피부 노화방지 효과 및 미백효과를 갖는 화장료 조성물”에는 잎새버섯 균사체 추출물 또는 잎새버섯 균사체 배양액으로부터 저분자 물질을 제거한 후에 얻은 추출물을 조성물 총 중량에 대하여 0.00001~30중량%의 양으로 함유하는 특징으로 하는 화장료 조성물에 대하여 기재하고 있다.Republic of Korea Patent No. 10-0438009 "Cosmetic composition having an anti-aging effect and whitening effect containing the extract of leaf mycelium mycelium" includes the extract obtained after removing the low-molecular substances from leaf mycelium mycelium extract or leaf mycelium mycelium culture It describes about the cosmetic composition characterized by containing it in the quantity of 0.00001-30 weight% with respect to weight.
또한, 대한민국 특허출원 제10-2009-0116193호 “잎새버섯 추출물을 유효성분으로 함유하는 염증성 장질환 치료 및 예방용 약학조성물”은 잎새버섯 추출물을 유효성분으로 함유하는 염증성 장질환 치료 및 예방용 약학 조성물에 대하여 기재하고 있다.In addition, the Republic of Korea Patent Application No. 10-2009-0116193 "Pharmaceutical composition for the treatment and prevention of inflammatory bowel disease containing leaf mushroom extract as an active ingredient" is a pharmaceutical for treating and preventing inflammatory bowel disease containing leaf mushroom extract as an active ingredient The composition is described.
이와 같이 잎새버섯에 대한 연구가 최근 이루어지기는 하였으나, 잎새버섯 세포외다당체의 분자량과 그의 생리학적 기능의 상관관계에 대하여는 아직까지 연구가 이루어지지 않았다. 본 발명자들은 이에 주목하여 예의 연구 검토한 결과, 본 발명에 이르게 되었다.
Thus, although the research on leaf mushrooms has been recently made, the correlation between the molecular weight of leaf mushroom extracellular polysaccharide and its physiological function has not been studied yet. MEANS TO SOLVE THE PROBLEM The present inventors came to this invention as a result of earnestly researching and paying attention to this.
버섯 유래의 수용성 다당체는 난용성 문제를 갖지는 않으나, 인체 적용시 그 생리학적 기능이 만족스러울 정도로 충분히 발휘되지 못하였다. 이에, 본 발명에서는 이를 다당체를 저분자화함으로써 상기에 대한 해결 방안을 제시하고자 한다.
Water-soluble polysaccharides derived from mushrooms do not have poor solubility problems, but their physiological functions have not been sufficiently demonstrated in human application. Accordingly, the present invention intends to propose a solution to the above by making the polysaccharide low molecule.
본 발명에 따르면, 방사선 조사에 의해 잎새버섯 균사체 세포외다당체를 저분자화하는 방법을 제공한다.According to the present invention, there is provided a method of low molecular weight mycelium mycelium extracellular polysaccharide by irradiation.
또한, 본 발명에 따르면, 상기 방법으로부터 수득된 저분자화된 잎새버섯 균사체 세포외다당체를 제공한다.According to the present invention, there is also provided a low molecular weight leaf mushroom mycelium extracellular polysaccharide obtained from the above method.
또한, 본 발명에 따르면, 저분자화된 잎새버섯 균사체 세포외다당체를 포함하는 화장료 조성물을 제공한다.In addition, according to the present invention, it provides a cosmetic composition comprising a low molecular weight leaf mushroom mycelium extracellular polysaccharide.
또한, 본 발명에 따르면, 저분자화된 잎새버섯 균사체 세포외다당체를 포함하는 식품조성물을 제공한다.
In addition, according to the present invention, there is provided a food composition comprising a low molecular weight leaf mushroom mycelium extracellular polysaccharide.
본 발명에 따른 저분자화된 잎새버섯 균사체 세포외다당체는 보다 향상된 생리학적 기능을 나타내는 것으로 증명되었다. 따라서, 이를 화장료 조성물에 사용시에 방사선 보호 효과 및 항산화 효과에 의해 탁월한 피부노화방지 효과를 나타낼 수 있고, 식품에 첨가 사용시에 면역증강효과 및 항암 효과를 나타낼 수 있다.
The low molecular weight mycelium mycelium extracellular polysaccharide according to the present invention has been shown to exhibit improved physiological function. Therefore, when used in the cosmetic composition it can exhibit an excellent skin anti-aging effect by the radiation protection effect and antioxidant effect, and when used in addition to food may exhibit an immune enhancing effect and an anticancer effect.
도 1은 잎새버섯을 나타낸 것이다.
도 2는 방사선 조사에 따른 분자량 변화를 나타낸 그래프이다.1 shows a leaf mushroom.
2 is a graph showing the change in molecular weight according to irradiation.
본 발명에 따르면, 잎새버섯 균사체는 잎새버섯 자실체에서 얻은 포자를 발아시켜 얻은 균사체를 고형배지 또는 액체배지에서 배양함으로써 얻을 수 있다. 그러나, 고형배지에 의할 경우, 배양기간이 길고, 균사체 수율이 낮으며, 균사체 배양이 균일하게 이루어지지 않고, 균사체 추출시 배지성분이 혼합될 우려가 있기에 액체배지에 의하는 것이 바람직하다.According to the present invention, leaf mycelium mycelium can be obtained by culturing the mycelium obtained by germinating spores obtained from the leaf mushroom fruiting body in a solid medium or a liquid medium. However, in the case of the solid medium, it is preferable to use the liquid medium because the culture period is long, the mycelia yield is low, the mycelium culture is not uniform, and the media components may be mixed during the mycelium extraction.
본 발명에 따르면, 조사되는 방사선은 코발트 60이나, 이에 한정되는 것은 아니고, 당업계에서 일반적으로 사용되는 방사선 종류를 모두 이용할 수 있다. 또한, 방사선은 저준위의 방사선 선량으로 일반적으로 조사되는 범위의 양으로 조사될 수 있으며, 바람직하게는 1 내지 50 kGy 범위이고, 더욱 바람직하게는 40 내지 50 kGy 범위의 양으로 조사될 수 있다.According to the present invention, the radiation to be irradiated is cobalt 60, but is not limited thereto, and any type of radiation generally used in the art may be used. In addition, the radiation may be irradiated in an amount in the range generally irradiated with a low level of radiation dose, preferably in the range of 1 to 50 kGy, more preferably in an amount in the range of 40 to 50 kGy.
본 발명에 따른 다당체는 화장료 조성물에 포함될 수 있다. 상기 다당체를 포함할 수 있는 화장료 조성물의 제형은 특별히 한정되지 않는다. 또한, 상기 다당체는 당업계에서 화장료 조성물에 통상적으로 사용되는 양으로 포함될 수 있다. 바람직하게, 상기 다당체는 화장료 조성물의 전체 중량을 기준으로 1 내지 15중량%의 양으로 포함될 수 있다.The polysaccharide according to the present invention may be included in the cosmetic composition. The formulation of the cosmetic composition which may include the polysaccharide is not particularly limited. In addition, the polysaccharide may be included in an amount commonly used in cosmetic compositions in the art. Preferably, the polysaccharide may be included in an amount of 1 to 15% by weight based on the total weight of the cosmetic composition.
본 발명의 화장료 조성물은 상기 다당체 이외에 화장료 조성물에서 통상적으로 이용되는 성분, 예컨대, 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 및 담체를 포함할 수 있다.The cosmetic composition of the present invention may include, in addition to the polysaccharide, components commonly used in cosmetic compositions, for example, conventional adjuvants such as antioxidants, stabilizers, solubilizers, vitamins, pigments and flavors, and carriers.
본 발명에 따른 다당체는 식품에 포함될 수 있다. 상기 다당체를 포함할 수 있는 식품은 그 종류 및 형태에 있어 특별히 한정되지 않는다. 바람직하게, 상기 다당체는 식품 전체 중량을 기준으로 식품 또는 음료의 제조시에 원료에 대하여 각각 0.0001 내지 30 중량%, 바람직하게는 0.1 내지 20 중량%의 양으로 첨가될 수 있으나, 첨가되는 양은 목적에 따라 얼마든지 조절이 가능하다.The polysaccharide according to the present invention may be included in food. The food which can contain the said polysaccharide is not specifically limited in the kind and form. Preferably, the polysaccharide may be added in an amount of 0.0001 to 30% by weight, preferably 0.1 to 20% by weight, based on the total weight of the food, based on the total weight of the food, respectively, based on the total weight of the food. You can adjust as much as you like.
이하, 본 발명을 하기에서 보다 상세히 설명한다. 그러나, 본 발명이 이에 한정되는 것은 아니다.
Hereinafter, the present invention will be described in more detail below. However, the present invention is not limited thereto.
1. 재료 및 방법1. Materials and Methods
(1) 균주 및 배지 조성(1) Strain and Medium Composition
본 연구에 사용된 잎새버섯 균주 (G. frondosa KCTC6726)는 한국 유전자 은행으로부터 분양받아 사용하였다. 보존용 배지는 감자한천배지(PDA, potato dextrose agar: pH 5.5)이며 25로 7일간 배양한 후 4에서 보존하며, 4주마다 계대배양하면서 사용하였다. 종균용 및 본배양용 배지는 Lilly-Barneet medium (글루코오즈 20.0g, 펩톤 2.0g, MgSO4·7H2O 0.5g, KH2PO4 1.0g, 물 1.0 리터) 조성을 응용하여 기본배지로 사용하였다. 종균배양액은 500mL 삼각플라스크에 기본배지 100mL을 넣고 접종비를 3%로 하여 25℃에서 3일간 120rpm으로 하여 배양하였다
The leaf mushroom strain ( G. frondosa KCTC6726) used in this study was distributed from Korea Gene Bank. The preservation medium was potato agar medium (PDA, potato dextrose agar: pH 5.5), incubated at 25 for 7 days and then preserved at 4, and used with subculture every 4 weeks. The seed and main culture medium was used as a basic medium by applying the composition of Lilly-Barneet medium (glucose 20.0g, peptone 2.0g, MgSO 4 · 7H 2 O 0.5g, KH 2 PO 4 1.0g, 1.0 liter of water). . The spawn culture solution was incubated at 120 rpm for 3 days at 25 ° C with 100 mL of basic medium in 500 mL Erlenmeyer flask.
(2) 균사체 증식과 다당체의 생성(2) Mycelial Growth and Polysaccharide Production
발효 배양시간에 따라 수집된 배양액을 8000xg에서 20분간 원심분리하여 얻은 균사체를 증류수로 2~3회 수세하고, 60℃에서 24시간 건조한 다음 건조중량을 측정하여 균체량을 정량하고, 세포외 다당체는 분리된 상등액(supernatant)을 여과지 (와트만(Whatman) No.2)로 여과된 여액에 4배량의 에탄올(95%)을 가한 다음 4℃에서 24시간 침전시켰다. 침전된 세포외 다당체를 8000xg에서 10분간 원심분리한 후, 동결건조한 세포외 다당체의 건조물을 정량하였다.
The mycelium obtained by centrifuging the culture broth collected at 8000xg for 20 minutes was washed 2 ~ 3 times with distilled water, dried at 60 ° C for 24 hours, and then weighed by measuring dry weight to separate the extracellular polysaccharide. The supernatant was added four times of ethanol (95%) to the filtrate filtered with filter paper (Whatman No. 2) and then precipitated at 4 ° C. for 24 hours. The precipitated extracellular polysaccharide was centrifuged at 8000xg for 10 minutes, and the dried product of the lyophilized extracellular polysaccharide was quantified.
(3) 분리 및 정제(3) Separation and Purification
발효배양액으로부터 균사체를 분리한 상등액에 4배량의 에탄올(95%)을 가한 후, 침전물을 원심분리하여 동결건조한 후, 조 다당체를 얻고, 분리된 균사체의 건조중량 50g을 증류수 50mL에 넣은 다음 100℃에서 4시간동안 열수 추출하여 여액을 얻었다. 이를 세포외다당체를 포함하는 균사체 추출물로서 사용하였다
After adding 4 times the amount of ethanol (95%) to the supernatant from which the mycelium was separated from the fermentation broth, the precipitate was centrifuged and lyophilized to obtain crude polysaccharide. 50 g of the dry weight of the isolated mycelium was added to 50 mL of distilled water, followed by 100 ° C. Hot water was extracted for 4 hours at to obtain a filtrate. This was used as mycelium extract containing extracellular polysaccharides.
2. 방사선 조사에 의한 본 발명의 다당류 특성 분석2. Analysis of Polysaccharide Characteristics of the Present Invention by Irradiation
잎새버섯 균사체 세포외다당체를 0.1g/mL의 농도로 PBS에 녹여 코발트 60 gamma-irradiator (10kGy/h) 로 방사선을 조사하였다. 조사 용량은 1, 10, 20, 30, 40 및 50 kGy내에서 다양하게 하였다. 방사선 조사 후, 샘플은 냉장상태로 보관하였다.Leaf fungus mycelium extracellular polysaccharide was dissolved in PBS at a concentration of 0.1 g / mL and irradiated with cobalt 60 gamma-irradiator (10 kGy / h). Irradiation doses varied within 1, 10, 20, 30, 40 and 50 kGy. After irradiation, the samples were stored refrigerated.
조사된 다당체의 분자량을 겔 투과 크로마토그래피 (GPC)로 측정하였다. 측정조건은 PLaquagel-60컬럼, 40컬럼, 30컬럼 (300 X 7.5mm, 8 mm, Polymerlaboratories, Ltd., UK)을 이용하며, 이동상은 0.1M sodiumnitrate, 흐름 속도는 1 mL/min로 하였다.The molecular weight of the polysaccharide investigated was measured by gel permeation chromatography (GPC). The measurement conditions were PLaquagel-60 columns, 40 columns, 30 columns (300 X 7.5mm, 8 mm, Polymerlaboratories, Ltd., UK), the mobile phase was 0.1M sodium nitrate, flow rate was 1 mL / min.
측정 결과, 방사선 조사선량이 높을수록 분자량의 크기가 감소하는 것으로 나타났다. 즉, 잎새버섯 균사체의 세포외다당체의 분자량은 210kDa이었고, 방사선 1kGy 후는 약 115kDa으로부터 시작하여 50kGy에서는 20kDa의 분자량 분포를 나타내었다 (도 1).
The results showed that the higher the radiation dose, the smaller the size of the molecular weight. That is, the molecular weight of the extracellular polysaccharide of the leaf mycelium was 210 kDa, and showed a molecular weight distribution of 20 kDa at 50 kGy starting from about 115 kDa after
3. 본 발명의 다당체의 생리학적 기능 평가3. Evaluation of the Physiological Function of the Polysaccharide of the Present Invention
(1) 방사선 보호 효과(1) radiation protection effect
10주령의 C57 검은 마우스를 1군당 10마리씩 사용하여 방사선 처리전 및 저분화된 다당체 처리후의 생존율을 측정하였다. 마우스에 대한 방사선 조사는 10 Gy로 하였다.Ten 10-week-old C57 black mice were used per group to determine survival before radiation and post-differentiated polysaccharide treatment. Irradiation to the mouse was 10 Gy.
시료 조제는 0.1g/mL의 농도로 다당체를 PBS에 녹인 후에 방사선 조사하여서 저분자화 다당류를 제조하였다. 시료 처리는 방사선 조사 6시간 전에 마우스의 복강 내로 주입하였다. 방사선 조사 후 40일 후 대조군 및 실험군의 사망율을 평가하였다. 그 결과를 다음 표 1에 기재하였다. The sample preparation was prepared by dissolving the polysaccharide in PBS at a concentration of 0.1 g / mL and irradiating the same to prepare a low molecular weight polysaccharide. Sample treatment was injected into the abdominal cavity of mice 6 hours prior to irradiation. Mortality of the control and experimental groups was assessed 40 days after irradiation. The results are shown in Table 1 below.
방사선 조사에 대한 보호효과의 경우, 분자량 크기가 작을수록 방사선 조사에 대한 보호 효과를 크게 나타내는 것으로 나타났다. 즉, 분자량 크기를 조절하지 않은 시료에서는 방사선 조사 후, 개체수가 사망하기 시작하여 10일째까지 2마리가 생존하였고, 11일째에는 모두 사망하였다. 그러나, 분자량 크기를 감소시킨 시료에서는 방사선 조사 후 생존율이 증가하였고, 분자량 크기 48, 32 및 20kDa의 시료에서는 방사선 조사 후 40일째에서도 생존 개체수가 관찰되었다. 따라서, 48kDa 이하의 분자량 크기에서 방사선 조사에 대한 보호 효과가 가장 우수하게 나타나는 것으로 평가되었다.
In the case of the protective effect against irradiation, the smaller the molecular weight, the greater the protective effect against irradiation. That is, in the sample which did not control the molecular weight size, after the irradiation, the population began to die, and two survived until the 10th day, and all died on the 11th day. However, the survival rate after irradiation was increased in the sample having reduced molecular weight size, and the survival population was observed even at 40 days after irradiation in the samples of
(2) (2) 항산화능Antioxidant ability 평가 evaluation
방사선 보호효과의 기전을 평가하기 위하여, 항산화능을 측정하였다. 항산화능은 DPPH 및 ABTS 라디칼 소거능으로 측정하였다.
In order to evaluate the mechanism of radiation protection effect, antioxidant activity was measured. Antioxidant activity was determined by DPPH and ABTS radical scavenging activity.
A. DPPH free radical 소거활성 측정A. Measurement of DPPH free radical scavenging activity
2,2-diphenyl-β-picrylhydrazyl(DPPH) free radical 소거활성법에 의하여 측정하였다. 즉, 2mg, 0.2mg 및 0.02mg의 시료를 4 mL의 메탄올에 녹여 1.5 x 10-4 M DPPH 용액(메탄올) 1 mL를 첨가한 후, 30분간 방치한 후에 517 nm에서 흡광도를 측정하였다. 이때 활성비교를 위하여 표준물질은 아스코르브산을 사용하였으며, 시료 무첨가구에 대한 첨가구의 흡광도 비로 나타내었다. 2,2-diphenyl-β-picrylhydrazyl (DPPH) free radical scavenging activity was measured. That is, 2 mg, 0.2 mg, and 0.02 mg of samples were dissolved in 4 mL of methanol, 1 mL of 1.5 × 10 −4 M DPPH solution (methanol) was added, and the absorbance was measured at 517 nm after being left for 30 minutes. At this time, ascorbic acid was used as a reference material for the activity comparison, and the absorbance ratio of the added group to the sample-free group was expressed.
DPPH 라디칼 소거능의 경우, 분자량의 크기를 조절하지 않은 시료에서의 소거능은 11% 이었으나, 분자량의 크기를 조절한 경우, 분자량의 크기가 작은 수록 소거능이 높은 것으로 나타났다. 그 결과를 하기 표 2에 기재하였다.In the case of DPPH radical scavenging ability, the scavenging ability of the sample without controlling the molecular weight was 11%. However, when the molecular weight was adjusted, the smaller the molecular weight, the higher the scavenging ability. The results are shown in Table 2 below.
B. ABTS 라디칼 소거활성 측정B. Determination of ABTS radical scavenging activity
총 항산화력은 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonate)(ABTS) cation decolorization assay 방법에 의하여 측정하였다. 즉, ABTS 7.4 mM과 potassium persulfate 2.6 mM을 12시간 암소에 방치하여 ABTS+ 이온을 형성시킨 후 이 용액을 734 nm에서 흡광도 값이 0.7이 되도록 증류수로 희석하였다. 희석된 ABTS용액 1 mL에 시료 500 을 가하여 실온에서 10분간 반응시켜 흡광도의 변화를 분광광도계를 이용하여 측정하였고(GE healthcare, Pischaway, NJ, USA) 시료첨가구와 무첨가구의 흡광도 비로 나타내었다. ABTS 라디칼 소거능의 경우, 역시 분자량의 크기를 조절하지 않은 시료에서의 소거능은 10% 이었으나, 분자량 크기를 감소시킨 경우, 분자량의 크기가 작을수록 소거능이 높은 것으로 나타났다. 그 결과를 하기 표 3에 기재하였다.Total antioxidant activity was measured by 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonate) (ABTS) cation decolorization assay method. That is, ABTS + ions were formed by leaving ABTS 7.4 mM and potassium persulfate 2.6 mM in a dark place for 12 hours, and then the solution was diluted with distilled water to have an absorbance of 0.7 at 734 nm. Sample 500 was added to 1 mL of diluted ABTS solution and reacted for 10 minutes at room temperature. The change in absorbance was measured using a spectrophotometer (GE healthcare, Pischaway, NJ, USA). In the case of ABTS radical scavenging ability, the scavenging ability was also 10% in the sample which did not control the size of the molecular weight, but when the molecular weight was reduced, the smaller the molecular weight, the higher the scavenging ability. The results are shown in Table 3 below.
상기 2 가지 분석법 둘다에서 48kDa 이하의 분자량 크기에서 라디칼 소거능이 높은 것으로 나타났다. 이러한 결과는 마우스를 이용한 생존율 시험의 결과와 일치하여, 잎새버섯 균사체 세포외다당체의 경우 분자량의 크기를 작게 조절하여 시료의 항산화 효능을 높일 수 있었고, 이러한 증가된 항산화능은 궁극적으로 방사선 조사후 유발되는 체내 라디칼의 소거에 기여하여 생존율을 높이는 것으로 판단된다.
Both assays showed high radical scavenging activity at molecular weight sizes of up to 48 kDa. These results are consistent with the results of the survival test using mouse, and the leaf mushroom mycelium extracellular polysaccharide was able to increase the antioxidant efficiency of the sample by controlling the size of the molecular weight small, and this increased antioxidant capacity ultimately induced after irradiation It is believed that the survival rate is increased by contributing to the elimination of radicals in the body.
4. 4. 저분자화된Low molecular weight 다당체를 포함하는 Containing polysaccharides 화장료Cosmetics 조성물 및 식품의 Of composition and food 제조예Manufacturing example
(1) 화장료 조성물의 제조예(1) Production Example of Cosmetic Composition
하기 표에 기재된 성분 및 그의 함량을 이용하여 화장료 조성물에서 통상적으로 이용되는 방법에 따라 크림 조성물을 제조하였다.Cream compositions were prepared according to the methods commonly used in cosmetic compositions using the ingredients and their contents set forth in the tables below.
(중량%)content
(weight%)
(중량%)content
(weight%)
본 발명의 저분자화된 잎새버섯 균사체 세포외다당체를 함유하는 화장료 조성물은 상기 제형 및 조성에 한정되지 않으며, 당업계에서 통상적으로 사용되는 방식에 따라 임의의 제형 및 조성으로 제조할 수 있다.
The cosmetic composition containing the low molecular weight mycelium mycelium extracellular polysaccharide of the present invention is not limited to the above formulations and compositions, and may be prepared in any formulations and compositions according to methods commonly used in the art.
(2) 식품의 제조예(2) Production example of food
본 발명의 잎새버섯 균사체 세포외다당체를 함유하는 하기와 같이 다양한 경로를 통하여 투여 가능한 제품을 만들 수 있으나, 그 용도가 하기 형태 및 조성으로 제한되는 것은 아니다.
The leaf fungus mycelium mycelium of the present invention can be made of a product that can be administered through various routes as follows, but the use is not limited to the following form and composition.
A. 캡슐제A. Capsule
잎새버섯 균사체 세포외다당체 20.0% (w/w), 유당 79.5% (w/w), 스테아르산 마그네슘 0.5%(w/w) 성분들을 혼합하고 각각 약 100 mg을 함유하는 캡슐로 분산한다.
Leaf fungus mycelium extracellular polysaccharide 20.0% (w / w), lactose 79.5% (w / w), 0.5% magnesium stearate (w / w) components are mixed and dispersed in a capsule containing about 100 mg each.
B. 정제B. Tablet
잎새버섯 균사체 세포외다당체 20.0% (w/w), 스테아르산 마그네슘 0.5% (w/w), 크로스카멜로스 나트륨 2.0% (w/w), 유당 76.5% (w/w), PVP(폴리비닐피롤리딘) 1.0% (w/w) 성분들을 결합하고 용매, 예컨대 메탄올을 사용하여 과립화한다. 그 후, 제형을 건조하고 적절한 타정기로 정제를 형성한다.
Leaf fungus mycelium extracellular polysaccharide 20.0% (w / w), magnesium stearate 0.5% (w / w), croscarmellose sodium 2.0% (w / w), lactose 76.5% (w / w), PVP (polyvinyl) Pyrrolidine) 1.0% (w / w) components are combined and granulated with a solvent such as methanol. Thereafter, the formulation is dried and tablets are formed with a suitable tablet press.
C. 음료C. Beverage
잎새버섯 균사체 세포외다당체 9중량%, 과당 10 중량 %, 정백당 1 중량%, 구연산나트륨 0.2 중량%에 정제수를 100 중량%가 되도록 첨가하고 교반하여 통상의 음료제조 방법으로 제조하였다.9% by weight of the mycelium mycelium extracellular polysaccharide, 10% by weight fructose, 1% by weight per white sugar, 0.2% by weight of sodium citrate was added to 100% by weight of purified water and stirred to prepare a conventional beverage production method.
Claims (4)
After centrifugation of mycelial culture of leafy mushroom (Grifola frondosa), 4 times of ethanol (95%) was added to the filtrate, and the supernatant was precipitated for 24 hours, and then centrifuged again to remove the supernatant, freeze-dried, The obtained extracellular polysaccharide is irradiated with cobalt 60 radiation (γ) at 10 kGy / h to lower the extracellular polysaccharide. A polysaccharide having a molecular weight of 48 kDa or less derived from a leaf fungus mycelium extracellular polysaccharide.
A homeostasis functional cosmetic composition comprising an extracellular polysaccharide derived from leaf mushroom mycelium having a molecular weight of 48 kDa or less as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100066255A KR101245730B1 (en) | 2010-07-09 | 2010-07-09 | A method of depolymerizing Grifola frondosa Exo-polysaccharides, Grifola frondosa Exo-polysaccharides obtained therefrom, and cosmetic composotion and food product containing them |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100066255A KR101245730B1 (en) | 2010-07-09 | 2010-07-09 | A method of depolymerizing Grifola frondosa Exo-polysaccharides, Grifola frondosa Exo-polysaccharides obtained therefrom, and cosmetic composotion and food product containing them |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120005682A KR20120005682A (en) | 2012-01-17 |
KR101245730B1 true KR101245730B1 (en) | 2013-03-25 |
Family
ID=45611679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100066255A KR101245730B1 (en) | 2010-07-09 | 2010-07-09 | A method of depolymerizing Grifola frondosa Exo-polysaccharides, Grifola frondosa Exo-polysaccharides obtained therefrom, and cosmetic composotion and food product containing them |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101245730B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0725772A (en) * | 1993-07-09 | 1995-01-27 | Japan Atom Energy Res Inst | Antibacterially active agent from polysaccharide by radiation treatment and production thereof |
JP2009191009A (en) | 2008-02-14 | 2009-08-27 | Yukiguni Maitake Co Ltd | Low molecular substance derived from grifola frondosa having immunostimulatory activity and antitumor activity |
JP2009201465A (en) * | 2008-02-29 | 2009-09-10 | Forestry & Forest Products Research Institute | Grifola froundosa yield-increasing agent, medium for grifola froundosa fruit-body cultivation using the same, medium or culture medium for proliferating grifola froundosa mycelium, and grifola froundosa cultivating method |
-
2010
- 2010-07-09 KR KR1020100066255A patent/KR101245730B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0725772A (en) * | 1993-07-09 | 1995-01-27 | Japan Atom Energy Res Inst | Antibacterially active agent from polysaccharide by radiation treatment and production thereof |
JP2009191009A (en) | 2008-02-14 | 2009-08-27 | Yukiguni Maitake Co Ltd | Low molecular substance derived from grifola frondosa having immunostimulatory activity and antitumor activity |
JP2009201465A (en) * | 2008-02-29 | 2009-09-10 | Forestry & Forest Products Research Institute | Grifola froundosa yield-increasing agent, medium for grifola froundosa fruit-body cultivation using the same, medium or culture medium for proliferating grifola froundosa mycelium, and grifola froundosa cultivating method |
Also Published As
Publication number | Publication date |
---|---|
KR20120005682A (en) | 2012-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101887956B1 (en) | Composition for skin lightening comprising extract of Ecklonia cava treated by enzyme | |
KR20130031704A (en) | Methods of culturing inonotus obliquus, phellinus linteus, ganoderma lucidum, sparassis crispa and vegetable worms using mushroom media | |
KR20190060511A (en) | A composition for antioxidating comprising extracts of fermented tenebrio molitor | |
US6251877B1 (en) | Composition for external application containing a β-1,6-branched-β-1,3-glucan | |
KR20090083083A (en) | Compositions comprising fermentative extract of orchidaceae for improving functions of skin | |
KR20130077802A (en) | The preparing method of immune improving agents | |
KR100815256B1 (en) | Fermented Rubus coreanus Miq. and the composition containing thereof | |
KR102117218B1 (en) | Composition for improving skin beauty comprising extract of fermented soybean fermented with Aspergillus cristatus strain | |
KR101458274B1 (en) | Cosmetic Composition Comprising Fermented Ginseng Extracts | |
KR101727788B1 (en) | Sargassum thunbergii hydrolysates that have high glucuronic acid cotent, preparation method thereof and antiaging cosmetic composition containing the same | |
KR102236071B1 (en) | Composition for Improving Skin Trouble Using an Extract of Centella asiatica or Paeonia lactiflora Cultured with Magma Seawater | |
KR20100007122A (en) | Anti-bacterial or anti-fungal composition | |
KR100708779B1 (en) | Cosmetic Composition containing the liposomised Asidian Tunic extract, having Anti-Aging Effect and Anti-Wrinkle Effect | |
KR101197101B1 (en) | Composition for skin whitening comprising extracts of Microalgae culture medium as an active ingredient | |
KR20110044966A (en) | Compositions for antioxidation | |
KR101245730B1 (en) | A method of depolymerizing Grifola frondosa Exo-polysaccharides, Grifola frondosa Exo-polysaccharides obtained therefrom, and cosmetic composotion and food product containing them | |
KR20100101257A (en) | Compositions for uv protection, anti-inflammatory, antioxidation and antiaging | |
KR102368892B1 (en) | A composition for anti-inflammatory comprising extracts of single leaf cremastra and sigesbeckia glabrescens makino | |
KR20190113371A (en) | Composition for skin-whitening and anti-winkle comprising extract of Poria cocos, Coix lachrymajobi and Stachys sieboldii fermented using Hericium erinaceum mycelium as effective component | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR20040105601A (en) | Cosmetic material | |
KR100534074B1 (en) | Cosmetic composition containing grain extract and fermented grain phellinus linteus extract, and cosmetics containing the same | |
KR20180065178A (en) | A composition of hydrogel mask pack using mushroom mycelium and hydrogel mask pack containing the same as an active ingredient | |
KR20170005534A (en) | The Cosmetic composition containing the culture medium of mycelium from Elfvingia applanata using natural medium | |
KR20120119520A (en) | Composition for skin external application containing sap of bamboo fermented extracts using bacteria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20151223 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20170111 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20180302 Year of fee payment: 6 |